Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Vasodilatation
ADR ID BADD_A04542
ADR Hierarchy
23      Skin and subcutaneous tissue disorders
23.06      Skin vascular abnormalities
23.06.05      Skin vasomotor conditions
23.06.05.006      Vasodilatation
24      Vascular disorders
24.03      Vascular disorders NEC
24.03.02      Non-site specific vascular disorders NEC
24.03.02.003      Vasodilatation
Description The physiological widening of BLOOD VESSELS by relaxing the underlying VASCULAR SMOOTH MUSCLE. | VASODILATION that is mediated via the ENDOTHELIUM-DEPENDENT RELAXING FACTORS or their processes. [MeSH]
MedDRA Code 10047141
MeSH ID D014664
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Dilated veins | Skin vasodilatation | Skin vasodilating | Vasodilatation | Vein distended | Capillarectasia | Peripheral vasodilatation | Distended blood vessels | Vasodilation | Vasorelaxation | Vascular Endothelium-Dependent Relaxation | Endothelium-Dependent Relaxation, Vascular | Relaxation, Vascular Endothelium-Dependent | Vascular Endothelium Dependent Relaxation
ADR Related Proteins
Protein Name UniProt AC TTD Target ID
Not AvailableNot AvailableNot Available
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D02105Tacrolimus--
BADD_D02112Tamoxifen citrate--
BADD_D02163Terbutaline sulfate--
BADD_D02192Thalidomide--
BADD_D02211Tiagabine hydrochloride--
BADD_D02220Timolol maleate--
BADD_D02230Tizanidine--
BADD_D02231Tizanidine hydrochloride--
BADD_D02236Tofacitinib0.001158%
BADD_D02252Tositumomab--
BADD_D02254Tramadol--
BADD_D02255Tramadol hydrochloride--
BADD_D02261Tranexamic acid0.014288%
BADD_D02266Trazodone--
BADD_D02267Trazodone hydrochloride--
BADD_D02269Treprostinil sodium--
BADD_D02346Venlafaxine--
BADD_D02347Venlafaxine hydrochloride--
BADD_D02363Vinorelbine--
BADD_D02369Voriconazole--
BADD_D02379Zaleplon--
BADD_D02392Zoledronic acid0.013122%
The 4th Page    First    Pre   4    Total 4 Pages